Parexel Parexel @Parexel

RT @HealthAdvances: To understand market access issues facing rare disease products in England, Kelly Cockerill, Director @HealthAdvances, led a podium presentation at #ISPORBarcelona to present findings from the first 5 years of the NICE HST program. Find out more: https://t.co/a2PCCNedUt https://t.co/L5kknpAjJm

6:24 PM - 14 Nov 18
Previous Tweet
PAREXEL

RT @JdeBetts: Our opportunities for CRAs span many countries. We're looking forward to connecting with pros...

Next Tweet
PAREXEL
PAREXEL

FDA Inspection Processes: What should you anticipate? PAREXEL's Robert Iser dives into this issue at this y...

×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!